For stroke, the CNSR-III investigators examined residual inflammatory risk (RIR, risk associated with high CRP in patients with low on-treatment LDL) in a multicentre prospective cohort of over 10,000 stroke and TIA patients in China. This evidence concerns the gene CRP and stroke disorder.